Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Lorna Rodriguez-Rodriguez"'
Autor:
Thanh H. Dellinger, Mustafa Raoof, Michael P. O'Leary, Adrian Kohut, Yuman Fong, Michael Lew, Andrew M. Blakely, Joseph Chao, Paul Frankel, Amit Merchea, Dean Lim, Marc A. Reymond, Yanghee Woo, Marwan Fakih, Isaac Benjamin Paz, Mihaela C. Cristea, Lorna Rodriguez-Rodriguez, Thuy B. Tran, Gautam Malhotra, Richard L. Whelan
Publikováno v:
Annals of Surgical Oncology. 29:175-185
Peritoneal metastases (PM) from ovarian, gastric, appendiceal, or colorectal origin can be treated via cytoreductive surgery with or without the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) for selected patients. Unfortunately, not a
Autor:
James Shen, Mihaela C. Cristea, Scott Glaser, Christina Hsiao Wei, Daphne Stewart, Siamak Saadat, Edward Wang, Richard Li, Stephen J. Lee, Susan Shehayeb, Ernest S. Han, Thanh H. Dellinger, Sharon P. Wilczynski, Sariah Liu, Lorna Rodriguez-Rodriguez
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 2830, p 2830 (2020)
Journal of Clinical Medicine, Vol 9, Iss 2830, p 2830 (2020)
Epithelial ovarian cancer (EOC) is the most common histology of ovarian cancer defined as epithelial cancer derived from the ovaries, fallopian tubes, or primary peritoneum. It is the fifth most common cause of cancer-related death in women in the Un
Publikováno v:
CSurgeries.
Autor:
Lorna Rodriguez-Rodriguez
Publikováno v:
Advancing the Science of Cancer in Latinos ISBN: 9783030292850
Precision medicine in oncology aims to treat a patient based on the molecular makeup of the individual’s tumor. Guidelines have already been adopted in certain tumor types for the use of targeted therapies as standard of care, including lung, colon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f806b6e704d65614fa4a571a0ba9aef
https://doi.org/10.1007/978-3-030-29286-7_14
https://doi.org/10.1007/978-3-030-29286-7_14
Autor:
Levi Sokol, Kim M. Hirshfield, Chandrika Jeyamohan, Srilatha Simhadri, Janice M. Mehnert, Lorna Rodriguez-Rodriguez, Husam Al-Hraishawi, Shridar Ganesan, Sharon R. Pine, Atul Kulkarni, Suzie Chen, Man Lung Teo, Eileen White, Siraj M. Ali
Publikováno v:
Clinical Cancer Research. 23:5631-5638
Purpose: Many patients with BRAFV600E mutant melanoma treated with BRAF inhibitors experience a rapid response, but ultimately develop resistance. Insight into the mechanism of resistance is critical for development of more effective treatment strate
Autor:
Mihaela C. Cristea, Wei-Chien Lin, maria de leon, Mehdi Kebria, Amy Hakim, Lorna Rodriguez-Rodriguez, Edward Wang, Byrne Lee, Thanh H. Dellinger, Marianne Razavi, Ernest S. Han, Daphne Stewart, Mustafa Raoof, Mark T. Wakabayashi
Publikováno v:
Gynecologic Oncology. 162:S269
Objectives: To demonstrate safety and tolerability of HIPEC in ovarian cancer. Methods: A phase I, single-institution feasibility study was designed to evaluate the safety and feasibility of HIPEC at time of optimal cytoreductive surgery (CRS) in ova
Autor:
Elisa V. Bandera, Bo Qin, Lorna Rodriguez-Rodriguez, Valerie S. Lee, Lawrence H. Kushi, C. Bethan Powell
Publikováno v:
British Journal of Cancer
Background: Research on the effect of body mass index (BMI) on ovarian cancer survival is inconsistent, but previous studies did not consider the possible impact of ascites, bowel obstruction, or cachexia, which commonly occur in late-stage disease.